IPOX News.

Categories

Featured

IPOX Week
January 2nd, 2020
Read

Official IPOX® 2019 Returns

IPOX Week
January 1st, 2021
Read

Official IPOX® 2020 Returns

Breaking News
March 1st, 2021
Read

“Hot Pot” is hot – IPOX® heavyweight restaurant innovator Haidilao set to join key Hong Kong benchmark / [...]

Breaking News

IPOX® SPAC Information Center

September 21st, 2021
Read
IPOX Week

NEW! The IPOX® SPAC Index

June 30th, 2021
Read

All News

Breaking News

Surge in IL-based drug maker Abbvie propels IPOX 100 U.S. Index to big outsized [...]

IPOX Schuster LLC, the innovative Chicago-based Financial Services Firm behind the IPOX Indexes, is pleased to note fresh all-time highs in its IPOX [...]

Jan 26, 2018
Read
IPOX Week

The IPOX® Week (Jan 22, 2018)

Jan 22, 2018
Available in other languages
Read
Breaking News

French drugmaker Sanofi set to buy IPOX® 100 U.S. holding Bioverativ at 63% premium

IPOX Schuster LLC – the innovative Financial Services firms behind the IPOX® Indexes – is pleased to note news about the buyout of [...]

Jan 21, 2018
Read
IPOX Week

The IPOX® Week (Jan 15, 2018)

Jan 15, 2018
Available in other languages
Read
IPOX Week

The IPOX® Week (Jan 8, 2018)

Jan 08, 2018
Available in other languages
Read
Breaking News

IPOX 100 U.S. Index (IPXO) surges as 5-star FPX ETF passes USD billion 1 [...]

IPOX Schuster LLC (www.ipox.com), the innovative Financial Services firm behind the IPOX Indexes, is pleased to note a fresh all-time high in some [...]

Jan 04, 2018
Read

Discover How IPOX Can Benefit You

close

  • To access Supplemental Data, please complete your details and continue.

  • In an effort to protect IPOX Schuster and the valuable intellectual property we provide on this website, please acknowledge and accept the following terms and conditions prior to accessing the IPOX Indexes information and their respective data. The identifying information requested is not used for marketing purposes.
  • By clicking the acknowledgement box, you agree to be legally bound by terms set forth herein and you represent that you are accessing the content for you own personal, non-commercial investment purposes or that you are an agent of someone doing the same. The content accessed through this portal is not for professional or commercial use, including any investment management or institutional trading purposes and may not, in any manner, be copied, reproduced, modified, stored and/or used to create any derivative works. Notwithstanding anything to the contrary, all data and information is provided by IPOX Schuster LLC (IPOX Schuster) “as is”. Neither IPOX Schuster nor any of its affiliates or third party licensors guarantee the accuracy, completeness, timeliness or availability of any content nor are any such parties liable for any damages (direct, indirect, incidental, compensatory, punitive or consequential including, without limitation, lost income or lost profits) in connection with any use of such content. You hereby acknowledge that the content is general in nature and is not tailored to the needs of any person, entity or group of persons and IPOX Schuster does not address the suitability of any security. IPOX Schuster does not act as a fiduciary or an investment advisor. IPOX Schuster does not sponsor, endorse, sell, promote or manage any investment product of fund or other vehicle that is offered by third parties and that seeks to provide an investment return based on the returns of any IPOX Index. Display of any particular index on this site does not imply that IPOX Schuster claims any investment product using the index complies with any particular regulation, including but not limited to, ESMA Guidelines on ETFs and other UCITS issues.